JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 8, 2004; DOI: 10.1124/jpet.103.058388


0022-3565/04/3083-949-956$20.00
JPET 308:949-956, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.058388v1
308/3/949    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grover, B.
Right arrow Articles by Cacini, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grover, B.
Right arrow Articles by Cacini, W.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Reduced Expression of Organic Cation Transporters rOCT1 and rOCT2 in Experimental Diabetes

Brett Grover, Donna Buckley, Arthur R. Buckley, and William Cacini

Division of Pharmaceutical Sciences, College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, Ohio

Recent reports have documented a functional deficit of organic cation transport in diabetic rats by an unknown mechanism. This study was designed to test the hypothesis that experimental diabetes decreases expression of organic cation transporters at the basolateral membrane. Streptozotocin-induced diabetic rats were maintained for varying durations after induction of diabetes. A second group of age-matched control rats was maintained in a parallel manner. Kinetic analysis of tetraethylammonium accumulation in freshly isolated proximal tubular cells indicated a significantly lower Vmax value for the diabetics versus controls with no statistical difference in Km values between the two groups. Cortex sections were processed by standard procedures for Northern and immunoblot analysis. Protein expression of the organic cation transporters rOCT1 and rOCT2 progressively decreased with increasing duration of diabetes. After 21 days of diabetes, rOCT1 and rOCT2 were maximally reduced by 50 and 70%, respectively. Quantification of mRNA expression revealed that the roct1 transcript remained unchanged, whereas the roct2 transcript was decreased by 50% after 14 days of diabetes. Treatment with insulin prevented the reductions in transporter levels. These results support the hypothesis by demonstrating that experimental diabetes decreased expression of both rOCT1 and rOCT2 protein and also of roct2 mRNA accumulation. On the other hand, roct1 mRNA levels were unaffected by the diabetic state. This suggests that differences in rOCT2 protein may result from transcriptional and/or translational changes, whereas rOCT1 deficits may be due to posttranscriptional alterations.


Received for publication August 18, 2003
Accepted November 25, 2003.

Address correspondence to: Dr. William Cacini, College of Pharmacy, University of Cincinnati Medical Center, 3223 Eden Ave., Cincinnati, OH 45267-0004. E-mail: william.cacini{at}uc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
Q.-H. Hu, C. Wang, J.-M. Li, D.-M. Zhang, and L.-D. Kong
Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F1080 - F1091.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Pelis, R. C. Hartman, S. H. Wright, T. M. Wunz, and C. E. Groves
Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y. Alnouti, J. S. Petrick, and C. D. Klaassen
TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE
Drug Metab. Dispos., March 1, 2006; 34(3): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Ciarimboli, T. Ludwig, D. Lang, H. Pavenstadt, H. Koepsell, H.-J. Piechota, J. Haier, U. Jaehde, J. Zisowsky, and E. Schlatter
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Am. J. Pathol., December 1, 2005; 167(6): 1477 - 1484.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. C. Thomas, C. Tikellis, P. Kantharidis, W. C. Burns, M. E. Cooper, and J. M. Forbes
The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 456 - 466.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.